Unlock stock picks and a broker-level newsfeed that powers Wall Street.

HKSE - Delayed Quote USD

Global X ETF Series - Global X China Biotech ETF (9820.HK)

6.930
+0.155
+(2.29%)
At close: April 30 at 3:59:02 PM GMT+8

Top 10 Holdings (62.15% of Total Assets)

SymbolCompany% Assets
WuXi Biologics (Cayman) Inc. 9.21%
HENGRUI PHARMA 9.10%
WuXi AppTec Co., Ltd. 9.02%
INNOVENT BIO 8.22%
Akeso, Inc. 6.22%
Shanghai RAAS Blood Products Co., Ltd. 5.11%
SINO BIOPHARM 4.87%
Zai Lab Limited 3.68%
Hansoh Pharmaceutical Group Company Limited 3.37%
TIANTAN BIO 3.34%

Sector Weightings

Sector9820.HK
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 100.00%
Bonds 0.00%

Equity Holdings

Price/Earnings 0.04
Price/Book 0.35
Price/Sales 0.18
Price/Cashflow 0.05
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

ETF Overview

Category --
Fund Family Mirae Asset Global Investments (HK) Ltd
Net Assets 370.39M
YTD Daily Total Return --
Yield --
Legal Type Exchange Traded Fund

Related Tickers